(Q27640789)

2

0 references

Terry A Lyle

3

0 references

Philippe G Nantermet

4

0 references

Harold G Selnick

5

0 references

Richard C A Isaacs

6

0 references

S Dale Lewis

7

0 references

Bobby J Lucas

8

0 references

Julie A Krueger

9

0 references

Rominder Singh

10

0 references

Cynthia Miller-Stein

11

0 references

Rebecca B White

12

0 references

Bradley Wong

13

0 references

Elizabeth A Lyle

14

0 references

Maria T Stranieri

15

0 references

Jacquelynn J Cook

16

0 references

Daniel R McMasters

17

0 references

Janetta M Pellicore

18

0 references

Swati Pal

19

0 references

Audrey A Wallace

20

0 references

Franklin C Clayton

21

0 references

Dennis Bohn

22

0 references

Denise C Welsh

23

0 references

Joseph J Lynch

24

0 references

Youwei Yan

25

0 references

Zhongguo Chen

26

0 references

Lawrence Kuo

27

0 references

Stephen J Gardell

28

0 references

Jules A Shafer

29

0 references

Joseph P Vacca

Bioorganic & Medicinal Chemistry Letters

30

0 references

language of work or name

English

0 references

publication date

7 April 2003

0 references

published in

0 references

volume

13

0 references

issue

7

0 references

page(s)

1353-7

0 references

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Design and synthesis of potent and highly selective thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Pharmacologic Aspects of the Development of Selective Synthetic Thrombin Inhibitors as Anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Effect of a novel thrombin active-site inhibitor on arterial and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Rat model of arterial thrombosis induced by ferric chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021

The nature of .pi.-.pi. interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900099-4

7 January 2021